HEXB and Salla disease: Altogether, we demonstrate correction of several CNS pathologies and abnormalities with microglial replacement in the SD CNS, reiterating the therapeutic potential of this treatment paradigm over traditional BMT approaches and suggesting that infiltrating Hexb-sufficient BM-derived myeloid cells can improve neuronal pathologies and astrocyte activation in SD.